Santhera Pharmaceuticals Holding AG
SIX:SANN.SW
Overview | Financials
Company Name | Santhera Pharmaceuticals Holding AG |
Symbol | SANN.SW |
Currency | CHF |
Price | 9.05 |
Market Cap | 109,560,078 |
Dividend Yield | 0% |
52-week-range | 8.1 - 14.62 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Thomas Meier Ph.D. |
Website | https://www.santhera.com |
An error occurred while fetching data.
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD